These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 39109990

  • 21. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
    Roze S, Isitt J, Smith-Palmer J, Javanbakht M, Lynch P.
    Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
    [Abstract] [Full Text] [Related]

  • 22. Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the united states.
    Tunis SL, Minshall ME.
    Am J Manag Care; 2008 Mar; 14(3):131-40. PubMed ID: 18333705
    [Abstract] [Full Text] [Related]

  • 23. Beyond HbA1c.
    Bloomgarden Z.
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E, Lim BK, Fun S, Tong J, Yeoh LY, Sum CF, Subramaniam T, Lim SC.
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [Abstract] [Full Text] [Related]

  • 25. Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia.
    Isitt JJ, Roze S, Tilden D, Arora N, Palmer AJ, Jones T, Rentoul D, Lynch P.
    Diabet Med; 2022 Jul; 39(7):e14831. PubMed ID: 35298036
    [Abstract] [Full Text] [Related]

  • 26. Intermittently scanned continuous glucose monitoring provides no benefit over structured self-monitoring of blood glucose in type 2 diabetes not on prandial insulin, in the context of diabetes self-management education: GLucose monitoring programme SingaporE (GLiMPSE).
    Rama Chandran S, Rahman N, Gandhi M, Tan NC, Phoon IKY, Seah DEJ, Cheah MH, Sek K, Gardner DS.
    Diabetes Res Clin Pract; 2024 May; 211():111678. PubMed ID: 38642860
    [Abstract] [Full Text] [Related]

  • 27. Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands.
    Roze S, Duteil E, Smith-Palmer J, de Portu S, Valentine W, de Brouwer BF, Reznik Y, de Valk HW.
    J Med Econ; 2016 Aug; 19(8):742-9. PubMed ID: 26985982
    [Abstract] [Full Text] [Related]

  • 28. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S, Smith-Palmer J, Valentine WJ, Cook M, Jethwa M, de Portu S, Pickup JC.
    J Med Econ; 2016 Aug; 19(3):236-42. PubMed ID: 26510389
    [Abstract] [Full Text] [Related]

  • 29. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J, McKay A, Ridyard C, Thornborough K, Bedson E, Peak M, Didi M, Annan F, Gregory JW, Hughes D, Gamble C.
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [Abstract] [Full Text] [Related]

  • 30. Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland.
    Brändle M, Erny-Albrecht KM, Goodall G, Spinas GA, Streit P, Valentine WJ.
    Int J Clin Pharmacol Ther; 2009 Aug; 47(8):501-15. PubMed ID: 19640359
    [Abstract] [Full Text] [Related]

  • 31. Long-Term Cost-Effectiveness of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Adults With Type 1 Diabetes in Iran.
    Molaee MC, Naseri ZG, Karami MA.
    Value Health Reg Issues; 2024 Sep; 43():101002. PubMed ID: 38820700
    [Abstract] [Full Text] [Related]

  • 32. Cost-Effectiveness of the FreeStyle Libre® System Versus Blood Glucose Self-Monitoring in Individuals with Type 2 Diabetes on Insulin Treatment in Sweden.
    Jendle J, Eeg-Olofsson K, Svensson AM, Franzen S, Lamotte M, Levrat-Guillen F.
    Diabetes Ther; 2021 Dec; 12(12):3137-3152. PubMed ID: 34694584
    [Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland.
    Brändle M, Azoulay M, Greiner RA.
    Int J Clin Pharmacol Ther; 2007 Apr; 45(4):203-20. PubMed ID: 17474539
    [Abstract] [Full Text] [Related]

  • 34. Cost-effectiveness of continuous glucose monitoring with FreeStyle Libre® in Brazilian insulin-treated patients with types 1 and 2 diabetes mellitus.
    Bahia L, Mello KF, Lemos LLP, Costa NL, Mulinari E, Malerbi DA.
    Diabetol Metab Syndr; 2023 Nov 25; 15(1):242. PubMed ID: 38001509
    [Abstract] [Full Text] [Related]

  • 35. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC).
    Herman WH, Braffett BH, Kuo S, Lee JM, Brandle M, Jacobson AM, Prosser LA, Lachin JM.
    J Diabetes Complications; 2018 Oct 25; 32(10):934-939. PubMed ID: 30064713
    [Abstract] [Full Text] [Related]

  • 36. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL, Willis WD, Foos V.
    Curr Med Res Opin; 2010 Jan 25; 26(1):163-75. PubMed ID: 19919377
    [Abstract] [Full Text] [Related]

  • 37. Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada.
    Tunis SL, Sauriol L, Minshall ME.
    Appl Health Econ Health Policy; 2010 Jan 25; 8(4):267-80. PubMed ID: 20578781
    [Abstract] [Full Text] [Related]

  • 38. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
    Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C, DIAMOND Study Group.
    J Diabetes Sci Technol; 2017 Nov 25; 11(6):1138-1146. PubMed ID: 28449590
    [Abstract] [Full Text] [Related]

  • 39. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
    Jendle J, Pöhlmann J, de Portu S, Smith-Palmer J, Roze S.
    Diabetes Technol Ther; 2019 Mar 25; 21(3):110-118. PubMed ID: 30785311
    [Abstract] [Full Text] [Related]

  • 40. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.
    Teo E, Hassan N, Tam W, Koh S.
    Diabetologia; 2022 Apr 25; 65(4):604-619. PubMed ID: 35141761
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.